Evidence map›Paper›PMID 36879205›Full record

ArticleBMC ophthalmology2023

Multiple branch retinal artery occlusions following the new facial cosmetic filler (Poly-D, L-lactic Acid) injection a case report.

I Wang, Hui-Ju Lin, Yi-Yu Tsai, Wen-Lu Chen, Chun-Ju Lin, San-Ni Chen, Ming-Chieh Hsieh, Lei Wan, Peng-Tai Tien

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

I WangDepartment of Ophthalmology, Eye Center, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Hui-Ju LinDepartment of Ophthalmology, Eye Center, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Yi-Yu TsaiDepartment of Ophthalmology, Eye Center, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Wen-Lu ChenDepartment of Ophthalmology, Eye Center, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Chun-Ju LinDepartment of Ophthalmology, Eye Center, China Medical University Hospital, China Medical University, Taichung, Taiwan.
San-Ni ChenDepartment of Ophthalmology, Eye Center, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Ming-Chieh HsiehDepartment of Ophthalmology, Eye Center, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Lei WanSchool of Chinese Medicine, China Medical University, Taichung, Taiwan. leiwan@cmu.edu.tw.ORCID http://orcid.org/0000-0002-9525-3232
Peng-Tai TienDepartment of Ophthalmology, Eye Center, China Medical University Hospital, China Medical University, Taichung, Taiwan. miketien913@gmail.com.
China Medical University · TWAsia University · TW

Funding

Ministry of Science and Technology, Taiwan MOST107-2320-B-039-049-MY3
6 · The paper itself

Abstract

backgroundPoly-D, L-lactic acid is (PDLLA) a new cosmetic filler. We reported the first case of PDLLA-related devastating complication of multiple branch retinal artery occlusion (BRAO). CASE PRESENTATION: A 23-year-old female had sudden blindness after injection of PDLLA at the glabella. After emergency intraocular pressure-lowering medicine, ocular massage, steroid pulse therapy, heparin and alprostadil infusion, and subsequent treatments including acupuncture and 40 sessions of hyperbaric oxygen therapy, her best-corrected visual acuity improved from hand motion at 30 cm to 0.3 within 2 months.

conclusionAlthough safety of PDLLA was evaluated in animal studies and in 16,000 human cases, it could still cause rare but devastating retinal artery occlusion as in the present case. Proper and immediate therapies could still improve patient's vision and scotoma. Surgeons should keep in mind the possibility of iatrogenic filler-related retinal artery occlusion.

Indexed as

FaceRetinal Artery OcclusionAdultAnimalsEyeFemaleHumansInjectionsLactic AcidYoung AdultLactic AcidCase reportFillerHyperbaric oxygen therapyPDLLARetinal artery occlusionVision loss

Identifiers

PMID36879205
PMCPMC9987043
OpenAlexW4323313616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.